$0.94 Earnings Per Share Expected for Baxter International Inc. (NYSE:BAX) This Quarter

Brokerages forecast that Baxter International Inc. (NYSE:BAX) will post $0.94 earnings per share for the current quarter, Zacks reports. Six analysts have issued estimates for Baxter International’s earnings. The highest EPS estimate is $0.96 and the lowest is $0.93. Baxter International posted earnings of $0.83 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 13.3%. The company is scheduled to issue its next quarterly earnings report on Thursday, November 4th.

On average, analysts expect that Baxter International will report full-year earnings of $3.53 per share for the current fiscal year, with EPS estimates ranging from $3.50 to $3.55. For the next year, analysts forecast that the company will post earnings of $4.01 per share, with EPS estimates ranging from $3.95 to $4.09. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that cover Baxter International.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Wednesday, July 28th. The medical instruments supplier reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.05. Baxter International had a net margin of 9.18% and a return on equity of 19.07%. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.11 billion.

A number of analysts have recently commented on BAX shares. SVB Leerink reiterated a “buy” rating on shares of Baxter International in a research note on Sunday, September 5th. Piper Sandler dropped their price objective on shares of Baxter International from $85.00 to $82.00 and set a “neutral” rating on the stock in a report on Thursday, July 29th. Cowen raised shares of Baxter International from a “market perform” rating to an “outperform” rating and set a $98.00 price objective on the stock in a report on Monday, September 13th. Stifel Nicolaus dropped their price objective on shares of Baxter International from $95.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, July 29th. Finally, The Goldman Sachs Group dropped their price objective on shares of Baxter International from $93.00 to $80.00 and set a “neutral” rating on the stock in a report on Tuesday, August 3rd. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Baxter International presently has an average rating of “Buy” and an average price target of $91.08.

Hedge funds have recently added to or reduced their stakes in the company. MAI Capital Management lifted its holdings in shares of Baxter International by 17.0% in the first quarter. MAI Capital Management now owns 15,547 shares of the medical instruments supplier’s stock worth $1,311,000 after buying an additional 2,263 shares in the last quarter. New York State Common Retirement Fund increased its position in Baxter International by 9.8% in the first quarter. New York State Common Retirement Fund now owns 2,750,786 shares of the medical instruments supplier’s stock worth $232,001,000 after purchasing an additional 245,223 shares during the last quarter. Russell Investments Group Ltd. increased its position in Baxter International by 4.1% in the first quarter. Russell Investments Group Ltd. now owns 202,004 shares of the medical instruments supplier’s stock worth $17,039,000 after purchasing an additional 7,998 shares during the last quarter. Community Bank N.A. increased its position in Baxter International by 3.2% in the second quarter. Community Bank N.A. now owns 10,525 shares of the medical instruments supplier’s stock worth $847,000 after purchasing an additional 325 shares during the last quarter. Finally, Jarislowsky Fraser Ltd increased its position in Baxter International by 1.6% in the second quarter. Jarislowsky Fraser Ltd now owns 640,280 shares of the medical instruments supplier’s stock worth $51,542,000 after purchasing an additional 9,826 shares during the last quarter. 84.04% of the stock is currently owned by hedge funds and other institutional investors.

Shares of BAX stock traded down $0.82 during trading hours on Wednesday, reaching $82.79. The company had a trading volume of 26,016 shares, compared to its average volume of 2,918,490. The business has a fifty day moving average price of $78.43 and a 200-day moving average price of $81.35. Baxter International has a one year low of $73.12 and a one year high of $88.32. The firm has a market cap of $41.39 billion, a PE ratio of 38.18, a price-to-earnings-growth ratio of 2.29 and a beta of 0.66. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.78 and a current ratio of 2.39.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 1st. Stockholders of record on Friday, September 3rd will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Thursday, September 2nd. Baxter International’s dividend payout ratio (DPR) is presently 36.25%.

Baxter International Company Profile

Baxter International, Inc provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services.

Recommended Story: S&P/ASX 200 Index

Get a free copy of the Zacks research report on Baxter International (BAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.